Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06162676 · ClinicalTrials.gov registry record · NA

Game-Based Intervention to Promote HPV Vaccination

A NA study of HPV Infection and Vaccine-Preventable Diseases, sponsored by Michigan State University.

Active
Registry status
NA
Development phase
131
Enrollment target
1
Study location

NCT06162676 is a NA study of HPV Infection and Vaccine-Preventable Diseases that is active but no longer recruiting, run by Michigan State University. The registered enrollment target is 131 participants, below the 226-participant average among 13 other HPV Infection trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06162676, a NA study of HPV Infection and Vaccine-Preventable Diseases, is active but no longer recruiting, sponsored by Michigan State University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
131 participants
Enrollment target
1
Study location

Study Summary

This study will examine the feasibility and acceptability of an innovative game-based intervention designed for families of youth aged 11-14 to promote HPV vaccination; will explore changes in key outcomes and related measures; and will identify factors contributing to or impeding effective implementation in health clinic settings. The intervention and its approach have the potential to reduce health disparities in HPV-associated cancers in youth via low-cost technology and timely intervention.

Interventions

  • BEHAVIORAL HPV game

Study Locations (1)

Michigan

  • Michigan State University - East Lansing

Trial Details

FieldValue
Enrollment Target 131 participants
Start Date 2024-04-01
Est. Completion 2026-02-28
Phase NA

Sponsor

Michigan State University

120 total trials

What the Registry Record Tells You About NCT06162676

The ClinicalTrials.gov registry entry for NCT06162676 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 226-participant average among 13 other HPV Infection trials with a reported enrollment target (42% lower). The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HPV Infection appearing as the primary indexed condition, and to 1 intervention - of which HPV game is the first listed.

NCT06162676 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT06162676 about?

NCT06162676 is a clinical study titled "Game-Based Intervention to Promote HPV Vaccination". This study will examine the feasibility and acceptability of an innovative game-based intervention designed for families of youth aged 11-14 to promote HPV vaccination; will explore changes in key outcomes and related measures; and will identify factors contributing to or impeding effective implemen...

What is the current status of trial NCT06162676?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 131 participants. The study started on 2024-04-01. Estimated completion is 2026-02-28.

What conditions does trial NCT06162676 study?

This clinical trial studies the following conditions: HPV Infection, Vaccine-Preventable Diseases.

What interventions are being tested in trial NCT06162676?

The interventions under investigation include: HPV game (BEHAVIORAL).

Who is sponsoring clinical trial NCT06162676?

This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06162676 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HPV Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.